Per-protocol analysis of the ZINC trial for HIV disease among alcohol users

BACKGROUND: The Zinc for INflammation and Chronic disease in HIV (ZINC) trial randomized person who live with HIV (PLWH) who engage in heavy drinking to either daily zinc supplementation or placebo. The primary outcome was change in the Veterans Aging Cohort Study (VACS) index, a predictor of mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodi, Sara, Freiberg, Matthew, Gnatienko, Natalia, Blokhina, Elena, Yaroslavtseva, Tatiana, Krupitsky, Evgeny, Murray, Eleanor, Samet, Jeffrey H., Cheng, Debbie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989012/
https://www.ncbi.nlm.nih.gov/pubmed/33757560
http://dx.doi.org/10.1186/s13063-021-05178-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989012/
https://www.ncbi.nlm.nih.gov/pubmed/33757560
http://dx.doi.org/10.1186/s13063-021-05178-9

Ejemplares similares